AL
IntegraGen S.A.
ALINT.PA · PAR
0.08 € -14.91% (-0.01 €)
1M -51.09%
Market Cap 832.5K €
P/E Ratio -
Div. Yield -
ROE 346.46%
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.17x
PEG N/A
P/B N/A
Growth
0 /100
Declining Rev. growth 27.48%
FCF growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Net margin 53.06%
Op. margin 56.21%
FCF margin 31.43%
Quality
55 /100
Average ROE 346.46%
ROA 94.97%
Asset turnover 1.79x
Debt
25 /100
High Int. coverage -1,510.92x
Current ratio 1.30x
Net debt/EBITDA N/A
Stability
27 /100
Unstable Rev. volatility 19.19%
EPS volatility 2,682.96%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ALINT.PA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Berengere Genin
Employees
37
Headquarters
Évry